(Q57291492)
Statements
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe (English)
0 references
July 2010
0 references
293
0 references
1
0 references
92-98
0 references
1 reference